000			02119 a2200625 4500
005			20250515150833.0
264		0	_c20081210
008			200812s 0 0 eng d
022			_a1474-5488
024	7		_a10.1016/S1470-2045(08)70305-X _2doi
040			_aNLM _beng _cNLM
100	1		_aEdwards, Beatrice J
245	0	0	_aPharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. _h[electronic resource]
260			_bThe Lancet. Oncology _cDec 2008
300			_a1166-72 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650	0	4	_aAdministration, Oral
650	0	4	_aAdverse Drug Reaction Reporting Systems
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBone Density Conservation Agents _xadverse effects
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aDrug Approval
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aIncidence
650	0	4	_aInfusions, Intravenous
650	0	4	_aJaw _xdrug effects
650	0	4	_aMale
650	0	4	_aOsteonecrosis _xchemically induced
650	0	4	_aPamidronate
650	0	4	_aPrecipitating Factors
650	0	4	_aTooth Extraction
650	0	4	_aUnited States _xepidemiology
650	0	4	_aUnited States Food and Drug Administration
650	0	4	_aZoledronic Acid
700	1		_aGounder, Mrinal
700	1		_aMcKoy, June M
700	1		_aBoyd, Ian
700	1		_aFarrugia, Mathew
700	1		_aMigliorati, Cesar
700	1		_aMarx, Robert
700	1		_aRuggiero, Salvatore
700	1		_aDimopoulos, Meletios
700	1		_aRaisch, Dennis W
700	1		_aSinghal, Seema
700	1		_aCarson, Ken
700	1		_aObadina, Eniola
700	1		_aTrifilio, Steve
700	1		_aWest, Dennis
700	1		_aMehta, Jayesh
700	1		_aBennett, Charles L
773	0		_tThe Lancet. Oncology _gvol. 9 _gno. 12 _gp. 1166-72
856	4	0	_uhttps://doi.org/10.1016/S1470-2045(08)70305-X _zAvailable from publisher's website
999			_c18494254 _d18494254